BACKGROUND: Affective and anxiety disorders (AfD & AnD) are the most common psychiatric diseases in the general population. This study's aim was to assess for the first time the psychometric properties of the Spanish translated versions of the Montgomery-Asberg Depression Rating Scale (MADRS) and the Hamilton Anxiety Rating Scale (HARS), which are widely used both in medical care and clinical research. PATIENTS AND METHOD: A cohort, observational, prospective and multicentre study was conducted in clinically stable or unstable patients with AfD and AnD. The scales were administered at baseline and in a second study visit one week or 2 months later (to stable or unstable patients, respectively). The internal consistency, temporary stability, inter-raters reliability, factorial structure, convergent and discriminant validity, and sensitivity to change were all assessed for both scales. RESULTS: One hundred and eight AfD patients and 106 AnD patients were recruited in 10 psychiatry care centres from a wide geographical distribution. Both scales showed adequate properties in terms of: a) discriminant validity (MADRS/HARS-Clinical Global Impression: p < 0.001); b) convergent validity (MADRS-Hamilton Depression Rating Scale: p < 0.05 and 0.01; MADRS/HARS-EuroQoL 5D: p < 0.05; HARS-State Trait Anxiety Inventory: p < 0.05); c) internal consistency (Cronbach's alpha: MADRS = 0.88; HARS = 0.89); d) test-retest and inter-raters reliability (intraclass correlation coefficient: MADRS = 0.94 and 0.98, respectively; HARS = 0.92 and 0.92), and, e) sensitivity to change (effect size: MADRS = 2.05; HARS = 1.36). CONCLUSIONS: Spanish versions of MADRS and HARS scales showed good psychometric properties, similar to those of the original scales. Therefore, these scales are suitable for use in clinical practice and research in Spain.
BACKGROUND: Affective and anxiety disorders (AfD & AnD) are the most common psychiatric diseases in the general population. This study's aim was to assess for the first time the psychometric properties of the Spanish translated versions of the Montgomery-Asberg Depression Rating Scale (MADRS) and the Hamilton Anxiety Rating Scale (HARS), which are widely used both in medical care and clinical research. PATIENTS AND METHOD: A cohort, observational, prospective and multicentre study was conducted in clinically stable or unstable patients with AfD and AnD. The scales were administered at baseline and in a second study visit one week or 2 months later (to stable or unstable patients, respectively). The internal consistency, temporary stability, inter-raters reliability, factorial structure, convergent and discriminant validity, and sensitivity to change were all assessed for both scales. RESULTS: One hundred and eight AfD patients and 106 AnD patients were recruited in 10 psychiatry care centres from a wide geographical distribution. Both scales showed adequate properties in terms of: a) discriminant validity (MADRS/HARS-Clinical Global Impression: p < 0.001); b) convergent validity (MADRS-Hamilton Depression Rating Scale: p < 0.05 and 0.01; MADRS/HARS-EuroQoL 5D: p < 0.05; HARS-State Trait Anxiety Inventory: p < 0.05); c) internal consistency (Cronbach's alpha: MADRS = 0.88; HARS = 0.89); d) test-retest and inter-raters reliability (intraclass correlation coefficient: MADRS = 0.94 and 0.98, respectively; HARS = 0.92 and 0.92), and, e) sensitivity to change (effect size: MADRS = 2.05; HARS = 1.36). CONCLUSIONS: Spanish versions of MADRS and HARS scales showed good psychometric properties, similar to those of the original scales. Therefore, these scales are suitable for use in clinical practice and research in Spain.
Authors: María José Fernández-Serrano; Laura Moreno-López; Miguel Pérez-García; María I Viedma-Del Jesús; María B Sánchez-Barrera; Antonio Verdejo-García Journal: Psychopharmacology (Berl) Date: 2011-04-12 Impact factor: 4.530
Authors: Joan Rovira; Guillermina Albarracin; Luis Salvador; Javier Rejas; Eduardo Sánchez-Iriso; Juan M Cabasés Journal: Community Ment Health J Date: 2012-04-08
Authors: A M Sánchez-Torres; L Moreno-Izco; R Lorente-Omeñaca; B Cabrera; A Lobo; A M González-Pinto; J Merchán-Naranjo; I Corripio; E Vieta; E de la Serna; A Butjosa; F Contreras; S Sarró; G Mezquida; M Ribeiro; M Bernardo; M J Cuesta Journal: Eur Arch Psychiatry Clin Neurosci Date: 2017-11-21 Impact factor: 5.270
Authors: A M Jiménez-Gordo; J Feliu; B Martínez; J de-Castro; N Rodríguez-Salas; N Sastre; Y Vilches; E Espinosa; J R Rodríguez-Aizcorbe; M González-Barón Journal: Support Care Cancer Date: 2008-06-05 Impact factor: 3.603
Authors: Jane M Simoni; John S Wiebe; John A Sauceda; David Huh; Giselle Sanchez; Virginia Longoria; C Andres Bedoya; Steven A Safren Journal: AIDS Behav Date: 2013-10
Authors: Marina De Salas-Cansado; Enrique Álvarez; José M Olivares; Jose L Carrasco; M Belén Ferro; Javier Rejas Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2012-10-21 Impact factor: 4.328
Authors: Javier García-Campayo; Antoni Serrano-Blanco; Baltasar Rodero; Rosa Magallón; Marta Alda; Eva Andrés; Juan V Luciano; Yolanda López del Hoyo Journal: Trials Date: 2009-04-23 Impact factor: 2.279